Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lung Adenocarcinoma Metastatic × Crizotinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 7 Relapsed Pediatric Solid Tumor 1 Recurrence 1 Lung Neoplasms 1 Lung Adenocarcinoma Metastatic 1 Granuloma, Plasma Cell 1 Gallbladder Neoplasms 1 ALK-positive NSCLC 1

Interventions

Crizotinib 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02946359 2016-11-02

A+C in Metastatic Lung Adenocarcinoma Cancer

Chinese PLA General Hospital

Phase 2 Unknown

Lung Adenocarcinoma Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡